SANGAMO THERAPEUTICS, INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sangamo Therapeutics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $10.7M.
  • Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$135M, a 46% increase year-over-year.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$258M, a 34.1% decline from 2022.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$192M, a 7.85% decline from 2021.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$178M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$135M $10.7M +$115M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$250M -$36.1M +$78.4M +68.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$328M -$49.1M -$70.2M -332% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$258M -$60.3M -$8.32M -16% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$250M -$104M -$51M -96% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$199M -$115M -$71.3M -165% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$127M $21.1M +$65.1M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$192M -$52M -$14.5M -38.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$178M -$53.2M -$5.47M -11.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$172M -$43.2M +$4M +8.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$176M -$44M +$1.96M +4.26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$178M -$37.5M +$3.11M +7.65% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 -$181M -$47.7M -$46.1M -2977% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$135M -$47.2M -$11.2M -31.3% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$124M -$45.9M -$3.02M -7.04% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$121M -$40.6M -$45.2M -991% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$75.8M -$1.55M +$25.8M +94.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$102M -$35.9M -$5.65M -18.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$95.9M -$42.9M -$763K -1.81% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$95.2M $4.56M +$23.2M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$118M -$27.3M -$14.5M -113% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$104M -$30.3M -$13.6M -82% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$90.3M -$42.2M -$22M -109% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$68.3M -$18.7M -$5.57M -42.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$62.8M -$12.8M -$489K -3.96% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$62.3M -$16.6M -$4.15M -33.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$58.1M -$20.2M -$3.56M -21.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$54.6M -$13.1M -$3.47M -36% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$51.1M -$12.4M +$6.61M +34.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$57.7M -$12.5M +$14.1M +53% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$71.8M -$16.6M -$138K -0.84% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$71.7M -$9.62M +$4.39M +31.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$76M -$19M -$9.72M -105% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$66.3M -$26.6M -$14.4M -119% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$51.9M -$16.5M -$11.2M -210% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$40.7M -$14M -$9.69M -224% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$31M -$9.25M -$1.7M -22.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 -$29.3M -$12.1M -$5.15M -73.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 -$24.2M -$5.32M +$2.25M +29.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$26.4M -$4.32M +$3.83M +47% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-18
Q3 2014 -$30.2M -$7.55M -$1.4M -22.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-18
Q2 2014 -$28.8M -$6.98M -$1.53M -28.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-18
Q1 2014 -$27.3M -$7.57M -$687K -9.98% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-18
Q4 2013 -$26.6M -$8.14M -$4.67M -134% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-25
Q3 2013 -$22M -$6.15M -$355K -6.13% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-25
Q2 2013 -$21.6M -$5.45M +$278K +4.85% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-25
Q1 2013 -$21.9M -$6.89M +$383K +5.27% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-25
Q4 2012 -$22.3M -$3.48M +$2.88M +45.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-24
Q3 2012 -$25.1M -$5.79M +$3.76M +39.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-24
Q2 2012 -$28.9M -$5.73M +$4.53M +44.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-24
Q1 2012 -$33.4M -$7.27M +$2.31M +24.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-24
Q4 2011 -$35.8M -$6.36M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 -$9.55M -$859K -9.88% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-26
Q2 2011 -$10.3M -$6.4M -166% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-26
Q1 2011 -$9.58M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-26
Q3 2010 -$8.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$3.86M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.